Congratulations to the Der/Cox/Bryant Lab Supergroup for particpating in this year's PanCAN PurpleStride! Although the 5K race was virtual, the impact was real; the Running RAScals raised a total of $10,211 (second place overall). Dr. Kirsten Bryant as the second-highest individual fundraiser, with a total of $6,606. This was the Running RAScals' seventh year … Continue reading PanCAN PurpleStride 2020
Der Named Computational Medicine Program 2020 Pilot Award Winner
The UNC Computational Medicine Program sought collaborative proposals from research areas in Cognitive Computing/Machine Learning; Image Analysis/Computer Vision; Computational and Mathematical Modeling; Bioinformatics and Computational Genomics; Health Informatics and Network Analysis. Channing Der and Co-PI, Jeremy Purvis, won for “A topological model of the cell cycle in KRAS-driven cancers." You can read more about Dr. … Continue reading Der Named Computational Medicine Program 2020 Pilot Award Winner
Der Lab Publishes in Cancer Discovery
UNC Lineberger’s Channing Der, PhD, and Antje Schaefer, PhD. UNC UNC Lineberger's Channing Der, Ph.D. Sarah Graham Kenan Distinguished Professor in the UNC School of Medicine Department of Pharmacology was the co-corresponding author of a paper published in Cancer Discovery. Antje Schaefer, Ph.D., research assistant professor in the UNC School of Medicine Department of Pharmacology, … Continue reading Der Lab Publishes in Cancer Discovery
Der Lab Volunteers at SECU Family House
December 15, 2019 On Sunday, the Der lab prepared a taco bar for the guests at the Family House. Together, they made ground beef, rice, beans, vegetables, and homemade pico de gallo served in soft tacos, as well as cookies and sweet tea. The Der lab also had the opportunity to sit down and eat … Continue reading Der Lab Volunteers at SECU Family House
Aaron Hobbs to Present in Postdoctoral Seminar Series
Come out to support Aaron Hobbs as he presents "Atypical KRASG12R mutant is impaired in PI3K signaling and macropinocytosis in pancreatic cancer." The talks will be held in the Pagano Conference Room on Monday, December 16th at 12:00 pm.
Channing Der Named AAAS Fellow
Channing Der has been named a Fellow of the American Association for the Advancement of Science (AAAS) for “distinguished contributions to the field of cancer research through the discovery of RAS in cancer and the elucidation of RAS oncoprotein function and therapies.” Der, who joined the UNC School of Medicine in 1992 as an associate … Continue reading Channing Der Named AAAS Fellow
Der Lab Goes Purple for Pancreatic Awareness
For the month of November, the Der and Cox labs have gone purely purple. The dress code is inspired by the official pancreatic cancer ribbon and is worn all month to bring awareness to pancreatic cancer. See ABC 11's interview with Dr. Jen Jen Yeh and Dr. Kirsten Bryant here. Photos courtesy of the UNC … Continue reading Der Lab Goes Purple for Pancreatic Awareness
Researchers find KRAS gene mutation differences have implications for pancreatic cancer treatment
A new study from University of North Carolina Lineberger Comprehensive Cancer Center researchers reveals important findings about how a common genetic mutation in pancreatic cancer works to drive tumor growth. In the journal Cancer Discovery, researchers led by UNC Lineberger’s Channing Der, PhD, and Aaron Hobbs, PhD, reported details of the role of a particular mutation … Continue reading Researchers find KRAS gene mutation differences have implications for pancreatic cancer treatment
Channing Der Speaks at MUSC
Cancer survivors, patients, caregivers, and friends, gathered for an awareness reception at Hollings Cancer Center at the Medical University of South Carolina (MUSC). Dr. Channing Der spoke on the latest developments in pancreatic cancer research and treatments. More on the event at MUSC.
Channing Der Interviewed by Science Magazine
Two new drugs finally hit ‘undruggable’ cancer target, providing hope for treatments By Jocelyn Kaiser Cancer researchers are making progress toward a goal that has eluded them for more than 30 years: shrinking tumors by shutting off a protein called KRAS that drives growth in many cancer types. A new type of drug aimed at KRAS … Continue reading Channing Der Interviewed by Science Magazine
Der Lab 